The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Open accessAbstract
Pathogenic Escherichia coli strains cause a wide variety of intestinal and extraintestinal infections. The widespread geographical clonal dissemination of intestinal pathogenic E. coli strains, such as E. coli O157:H7, is well recognized, and its spread is most often attributed to contaminated food products. On the other hand, the clonal dissemination of extraintestinal pathogenic E. coli (ExPEC) strains is also recognized, but the mechanism of their spread is not well explained. Here, I describe major pandemic clonal lineages of ExPEC based on multilocus sequence typing (MLST), and discuss possible reasons for their global dissemination. These lineages include sequence type (ST)131, ST393, ST69, ST95, and ST73, which are all associated with both community-onset and healthcare-associated infections, in particular urinary tract infections and bloodstream infections. As with many other types of drug-resistant Gram-negative and Gram-positive bacterial infections, drug-resistant ExPEC infections are recognized to be caused by a limited set of clonal lineages. However, reported observations on these major pandemic lineages suggest that the resistance phenotype is not necessarily the determinant of their clonal dissemination. Both epidemiological factors and their intrinsic biological 'fitness' are likely to contribute. An important public health and clinical concern is that pandemicity itself may be a determinant of progressive drug resistance acquisition by clonal lineages. New research is urgently needed to better understand the epidemiological and biological causes of ExPEC pandemicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, we identified specific STs linked to neonatal infections, such as E. coli ST119347, ST73 and ST9547,48, and K. pneumoniae ST43249 strains, which are typically drug-resistant strains and of clinical significance.”
From Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants. (2025) · cites this paper as [48]
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,203
Diarrheagenic Escherichia coli
Nataro, J. P., & Kaper, J. B. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.1.142 · Cited by 5,109
Sex and virulence in Escherichia coli : an evolutionary perspective
Wirth, T., Falush, D., Lan, R., Colles, F. M., Mensa, P., Wieler, L. H., Karch, H., Reeves, P. R., Maiden, M. C. J., Ochman, H., et al. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05172.x · Cited by 2,075
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,068
Johnson, J. R., & Stell, A. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315217 · Cited by 1,269
Epidemic Profile of Shiga-Toxin–Producing Escherichia coli O104:H4 Outbreak in Germany
Frank, C., Werber, D., Cramer, J. P., Askar, M., Faber, M., an der Heiden, M., Bernard, H., Fruth, A., Prager, R., Spode, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106483 · Cited by 1,139
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 881
OUTCOME FOR INFANTS OF VERY LOW BIRTHWEIGHT: SURVEY OF WORLD LITERATURE
Stewart, A. C. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92198-x · Cited by 835
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Nicolas-Chanoine, M.-H., Blanco, J., Leflon‐Guibout, V., Demarty, R., Alonso, M. P., Caniça, M., Park, Y. J., Lavigne, J., Pitout, J. D. D., & Johnson, J. R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm464 · Cited by 815
Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe
Coque, T. M., Baquero, F., & Cantón, R. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19044-en · Cited by 808
The Link between Phylogeny and Virulence in Escherichia coli Extraintestinal Infection
Picard, B., Garcia, J. S., Gouriou, S., Duriez, P., Brahimi, N., Bingen, E., Elion, J., & Denamur, E. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.546-553.1999 · Cited by 794
German Outbreak of Escherichia coli O104:H4 Associated with Sprouts
Buchholz, U., Bernard, H., Werber, D., Böhmer, M. M., Remschmidt, C., Wilking, H., Deleré, Y., der Heiden, M. A., Adlhoch, C., Dreesman, J. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106482 · Cited by 757
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Rogers, B. A., Sidjabat, H. E., & Paterson, D. L. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq415 · Cited by 727
Coque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J. D. D., Peixe, L. M. S. V., Baquero, F., Cantón, R., & Nordmann, P. (2008) · Emerging infectious diseases · doi:10.3201/eid1402.070350 · Cited by 702
Mobley, H. L. T., Green, D. M., Trifillis, A. L., Johnson, D. E., Chippendale, G. R., Lockatell, C. V., Jones, B. D., & Warren, J. W. (1990) · Infection and Immunity · doi:10.1128/iai.58.5.1281-1289.1990 · Cited by 550
Manges, A. R., Johnson, J. R., Foxman, B., O’Bryan, T. T., Fullerton, K. E., & Riley, L. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011265 · Cited by 529
Self-citationJohnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., & Castanheira, M. (2010) · Clinical Infectious Diseases · doi:10.1086/653932 · Cited by 511
Woodford, N., Ward, M. E., Kaufmann, M. E., Turton, J. F., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M., Cheasty, T., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh424 · Cited by 472
Peirano, G., & Pitout, J. D. D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.003 · Cited by 443
Extraintestinal pathogenic Escherichia coli : “The other bad E coli ”
Johnson, J. R., & Russo, T. A. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.121550 · Cited by 423
Phylogenetic Distribution of Extraintestinal Virulence‐Associated Traits inEscherichia coli
Johnson, J. R., Delavari, P., Kuskowski, M. A., & Stell, A. L. (2001) · The Journal of Infectious Diseases · doi:10.1086/317656 · Cited by 401
Clermont, O., Dhanji, H., Upton, M., Gibreel, T. M., Fox, A., Boyd, D. A., Mulvey, M. R., Nordmann, P., Ruppé, É., Sarthou, J. L., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp194 · Cited by 356
Johnson, J. R., Murray, A. C., Gajewski, A., Sullivan, M. M., Snippes, P., Kuskowski, M. A., & Smith, K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2161-2168.2003 · Cited by 347
A murine model of urinary tract infection
Hung, C., Dodson, K., & Hultgren, S. J. (2009) · Nature Protocols · doi:10.1038/nprot.2009.116 · Cited by 322
Doi, Y., Park, Y. S., Rivera, J. I., Adams‐Haduch, J. M., Hingwe, A. S., Sordillo, E. M., Lewis, J. S., Howard, W. J., Johnson, L. E., Polsky, B., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis942 · Cited by 302
Food Reservoir for Escherichia coli Causing Urinary Tract Infections
Vincent, C., Boerlin, P., Daignault, D., Dozois, C. M., Dutil, L., Galanakis, C., Reid‐Smith, R. J., Tellier, P.-P., Tellis, P. A., Ziebell, K. A., et al. (2009) · Emerging infectious diseases · doi:10.3201/eid1601.091118 · Cited by 298
Ewers, C., Grobbel, M., Stamm, I., Kopp, P. A., Diehl, I., Semmler, T., Fruth, A., Beutlich, J., Guerra, B., Wieler, L. H., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq004 · Cited by 279
Moulin-Schouleur, M., Répérant, M., Laurent, S., Brée, A., Mignon-Grasteau, S., Germon, P., Rasschaert, D., & Schouler, C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00037-07 · Cited by 272
Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli
Johnson, J. R., Tchesnokova, V. L., Johnston, B., Clabots, C., Roberts, P. L., Billig, M., Riddell, K., Rogers, P., Qin, X. G., Butler‐Wu, S. M., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis933 · Cited by 267
Johnson, J. R., Menard, M. L., Johnston, B., Kuskowski, M. A., Nichol, K. A., & Zhanel, G. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00297-09 · Cited by 265
Bingen, É., Picard, B., Brahimi, N., Mathy, S., Desjardins, P., Élion, J., & Denamur, É. (1998) · The Journal of Infectious Diseases · doi:10.1086/514217 · Cited by 255
Analysis of a Uropathogenic Escherichia coli Clonal Group by Multilocus Sequence Typing
Tartof, S. Y., Solberg, O. D., Manges, A. R., & Riley, L. W. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.12.5860-5864.2005 · Cited by 248
Self-citationDierikx, C. M., van Duijkeren, E., Schoormans, A. H. W., van Essen, A., Veldman, K. T., Kant, A., Huijsdens, X. W., van der Zwaluw, K., Wagenaar, J. A., & Mevius, D. J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks049 · Cited by 223
Tivendale, K. A., Logue, C. M., Kariyawasam, S., Jordan, D. M., Hussein, A., Li, G., Wannemuehler, Y. M., & Nolan, L. K. (2010) · Infection and Immunity · doi:10.1128/iai.00347-10 · Cited by 220
Suzuki, S., Shibata, N., Yamane, K., Wachino, J.-I., Ito, K., & Arakawa, Y. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn463 · Cited by 178
Lau, S. H., Reddy, S., Cheesbrough, J., Bolton, F. J., Willshaw, G. A., Cheasty, T., Fox, A. J., & Upton, M. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02065-07 · Cited by 175
Gibreel, T. M., Dodgson, A. R., Cheesbrough, J., Fox, A. J., Bolton, F. J., & Upton, M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr451 · Cited by 173
Cagnacci, S., Gualco, L., Debbia, E. A., Schito, G. C., & Marchese, A. E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00640-08 · Cited by 166
Possible Animal Origin of Human-Associated, Multidrug-Resistant, Uropathogenic Escherichia coli
Ramchandani, M. S., Manges, A. R., DebRoy, C., Smith, S. P., Johnson, J. R., & Riley, L. W. (2004) · Clinical Infectious Diseases · doi:10.1086/426819 · Cited by 157
Self-citationPeirano, G., van der Bij, A. K., Gregson, D. B., & Pitout, J. D. D. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.06025-11 · Cited by 153
Surveillance forEscherichia coliO157:H7 Infections in Minnesota by Molecular Subtyping
Bender, J. B., Hedberg, C. W., Besser, J. M., Boxrud, D. J., MacDonald, K. L., & Osterholm, M. T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370604 · Cited by 146
Pitout, J. D. D., Gregson, D. B., Campbell, L., & Laupland, K. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00247-09 · Cited by 145
Leflon‐Guibout, V., Blanco, J., Amaqdouf, K., Mora, A., Guize, L., & Nicolas-Chanoine, M.-H. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00734-08 · Cited by 138
Mora, A., López, C., Dabhi, G., Blanco, M., Blanco, J. E., Alonso, M. P., Herrera, A., Mamani, R. C., Bonacorsi, S., Moulin-Schouleur, M., et al. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-132 · Cited by 136
Selander, R. K., Korhonen, T. K., Väisänen-Rhen, V., WILLIAMS, P. H., Pattison, P. E., & Caugant, D. A. (1986) · Infection and Immunity · doi:10.1128/iai.52.1.213-222.1986 · Cited by 131
Peirano, G., Schreckenberger, P. C., & Pitout, J. D. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01763-10 · Cited by 128
Seagulls and Beaches as Reservoirs for Multidrug-ResistantEscherichia coli
Simões, R. R., Poirel, L., da Costa, P. M., & Nordmann, P. (2009) · Emerging infectious diseases · doi:10.3201/eid1601.090896 · Cited by 128
Pitout, J. D. D., Church, D. L., Gregson, D. B., Chow, B. L., McCracken, M., Mulvey, M. R., & Laupland, K. B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01377-06 · Cited by 125
Blanco, J., Mora, A., Mamani, R. C., Lopez, C., Blanco, M., Dahbi, G., Herrera, A., Blanco, J. E., Alonso, M. P., Garcı́a-Garrote, F., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr235 · Cited by 123
EPIDEMIC MULTIRESISTANT ESCHERICHIA COLI INFECTION IN WEST LAMBETH HEALTH DISTRICT
Phillips, I., King, A., Rowe, B., Eykyn, S. J., Gransden, W. R., Frost, J. A., & Gross, R. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91853-3 · Cited by 119
Johnson, J. R., Miller, S. A., Johnston, B., Clabots, C., & DebRoy, C. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01581-09 · Cited by 119
Arpin, C., Quentin, C., Grobost, F., Cambau, E., Robert, J., Dubois, V., Coulange, L., & André, C. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp108 · Cited by 117
Platell, J. L., Cobbold, R. N., Johnson, J. R., Heisig, A., Heisig, P., Clabots, C., Kuskowski, M. A., & Trott, D. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00306-11 · Cited by 116
Adams, S. M., Diep, B. A., Perdreau‐Remington, F., & Riley, L. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01025-12 · Cited by 116
Self-citationEndemic and Epidemic Lineages ofEscherichia colithat Cause Urinary Tract Infections
Manges, A. R., Tabor, H., Tellis, P. A., Vincent, C., & Tellier, P. (2008) · Emerging infectious diseases · doi:10.3201/eid1410.080102 · Cited by 115
Johnson, J. R., Porter, S. B., Zhanel, G. G., Kuskowski, M. A., & Denamur, É. (2012) · Infection and Immunity · doi:10.1128/iai.06388-11 · Cited by 114
A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis
Johnson, J. R., Manges, A. R., O’Bryan, T. T., & Riley, L. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09264-4 · Cited by 112
Self-citationPlatell, J. L., Johnson, J. R., Cobbold, R. N., & Trott, D. J. (2011) · Veterinary Microbiology · doi:10.1016/j.vetmic.2011.05.007 · Cited by 111
Pomba, C., da Fonseca, J. D., Baptista, B., Correia, J. D., & Martı́nez-Martı́nez, L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00896-08 · Cited by 107
Croxall, G., Hale, J., Weston, V., Manning, G., Cheetham, P., Achtman, M., & McNally, A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr349 · Cited by 105
Mora, A., Herrera, A., Mamani, R. C., López, C., Alonso, M. P., Blanco, J. E., Blanco, M., Dahbi, G., Garcı́a-Garrote, F., Pita, J., et al. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.01112-10 · Cited by 103
Poultry as reservoir for extraintestinal pathogenic Escherichia coli O45:K1:H7-B2-ST95 in humans
Mora, A., Viso, S., López, C., Alonso, M. P., Garcı́a-Garrote, F., Dabhi, G., Mamani, R. C., Herrera, A., Marzoa, J., Blanco, M., et al. (2013) · Veterinary Microbiology · doi:10.1016/j.vetmic.2013.08.007 · Cited by 102
Matsumura, Y., Yamamoto, M., Nagao, M., Hotta, G., Matsushima, A., Ito, Y., Takakura, S., & Ichiyama, S. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks278 · Cited by 101
Johnson, J. R., Delavari, P., O’Bryan, T. T., Smith, K., & Tatini, S. R. (2005) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2005.2.38 · Cited by 100
Manges, A. R., NATARAJAN, P., Solberg, O. D., Dietrich, P. S., & Riley, L. W. (2005) · Epidemiology and Infection · doi:10.1017/s0950268805005005 · Cited by 97
Self-citationFam, N., Leflon‐Guibout, V., Fouad, S., Aboul-Fadl, L., Marcon, E., Gamal, D., El-Defrawy, I., Aitta, A. A., Klena, J. D., & Nicolas-Chanoine, M.-H. (2010) · Microbial Drug Resistance · doi:10.1089/mdr.2010.0063 · Cited by 96
Johnson, J. R., & O’Bryan, T. T. (2000) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.7.2.265-273.2000 · Cited by 95
Comparison ofEscherichia coliST131 Pulsotypes, by Epidemiologic Traits, 1967–2009
Johnson, J. R., Nicolas-Chanoine, M.-H., DebRoy, C., Castanheira, M., Robiscek, A., Hansen, G. T., Weissman, S. J., Urban, C. M., Platell, J. L., Trott, D. J., et al. (2012) · Emerging infectious diseases · doi:10.3201/eid1804.111627 · Cited by 94
Olesen, B. R. S., Hansen, D. S., Nilsson, F., Frimodt-Møller, J., Leihof, R. F., Struve, C., Scheutz, F., Johnston, B., Krogfelt, K. A., & Johnson, J. R. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00346-13 · Cited by 93
Martínez-Medina, M., Mora, A., Blanco, M., López, C., Alonso, M. P., Bonacorsi, S., Nicolas-Chanoine, M.-H., Darfeuille–Michaud, A., Garcia-Gil, L. J., & Blanco, J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01484-09 · Cited by 93
Serotypes of Escherichia coli isolated from septicaemic chickens in Galicia (Northwest Spain)
Blanco, J. E., Blanco, M., Mora, A., Jansen, W. H., Garcı́a, V., Vázquez, M. L., & Blanco, J. (1998) · Veterinary Microbiology · doi:10.1016/s0378-1135(98)00182-5 · Cited by 91
Weissman, S. J., Chattopadhyay, S., Aprikian, P., Obata‐Yasuoka, M., Yarova‐Yarovaya, Y., Stapleton, A. E., Ba‐Thein, W., Dykhuizen, D. E., Johnson, J. R., & Sokurenko, E. V. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04985.x · Cited by 91
Solberg, O. D., Ajiboye, R. M., & Riley, L. W. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.4.1347-1351.2006 · Cited by 90
Self-citationAjiboye, R. M., Solberg, O. D., Lee, B. M., Raphael, E., DebRoy, C., & Riley, L. W. (2009) · Clinical Infectious Diseases · doi:10.1086/600301 · Cited by 85
Self-citationDistribution and Characteristics ofEscherichia coliClonal Group A1
Johnson, J. R., Murray, A. C., Kuskowski, M. A., Schubert, S., Prère, M. F., Picard, B., Colodner, R., Raz, R., & and the Trans-Global Initiative for Antimicrobial Resistance Analysis (TIARA) Investigators (2005) · Emerging infectious diseases · doi:10.3201/eid1101.040418 · Cited by 81
Johnson, J. R., Stell, A. L., Scheutz, F., O’Bryan, T. T., Russo, T. A., Carlino, U. B., Fasching, C. E., Kavle, J. A., van Dijk, L., & Gaastra, W. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1587-1599.2000 · Cited by 81
Endimiani, A., Hujer, K. M., Hujer, A. M., Pulse, M., Weiss, W. J., & Bonomo, R. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01198-10 · Cited by 77
Coelho, A., Mora, A., Mamani, R. C., López, C. M., González‐López, J. J., Larrosa, N., Quintero-Zárate, J. N., Dahbi, G., Herrera, A., Blanco, J., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq491 · Cited by 77
Mora, A., Blanco, M., López, C., Mamani, R. C., Blanco, J. E., Alonso, M. P., Garcı́a-Garrote, F., Dahbi, G., Herrera, A., Fernández, A. M., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.09.012 · Cited by 74
Johnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., Roberts, E. L., & DebRoy, C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00674-07 · Cited by 74
Bert, F., Johnson, J. R., Ouattara, B., Leflon-Guibout, V., Johnston, B., Marcon, E., Valla, D., Moreau, R., & Nicolas-Chanoine, M.-H. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00516-10 · Cited by 71
CANCER NEAR NUCLEAR INSTALLATIONS
Beral, V. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90189-9 · Cited by 70
Lee, M., Choi, H. J., Choi, J. Y., Song, M., Song, Y., Kim, S., Chang, H., Jung, S.-I., Ys, K., Ki, H. K., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.11.004 · Cited by 68
Rodriguez‐Villalobos, H., Bogaerts, P., Berhin, C., Bauraing, C., Deplano, A., Montesinos, I., Mendonça, R. D., Jans, B., & Glupczynski, Y. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq388 · Cited by 68
Ender, P. T., Gajanana, D., Johnston, B., Clabots, C., Tamarkin, F. J., & Johnson, J. R. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01361-09 · Cited by 67
Escherichia coli Serotype O15:K52:H1 as a Uropathogenic Clone
Prats, G., Navarro, F., Mirelis, B., Dalmau, D., Margall, N., Coll, P., Stell, A. L., & Johnson, J. R. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.201-209.2000 · Cited by 66
Brisse, S., Diancourt, L., Laouenan, C., Vigan, M., Caro, V., Arlet, G., Drieux, L., Leflon‐Guibout, V., Mentré, F., Jarlier, V., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00919-12 · Cited by 65
Jones, G., Warren, R. E., Skidmore, S., Davies, V. A., Gibreel, T. M., & Upton, M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn406 · Cited by 65
Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12)
Horner, C., Fawley, W. N., Morris, K. A., Parnell, P., Denton, M., & Wilcox, M. H. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt333 · Cited by 65
Izdebski, R., Baraniak, A., Fiett, J., Adler, A., Kazma, M., Salomon, J., Lawrence, C., Rossini, A., Salvia, A., Vidal, J., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01656-12 · Cited by 64
Smith, S. P., Manges, A. R., & Riley, L. W. (2008) · Clinical Infectious Diseases · doi:10.1086/527386 · Cited by 60
Self-citationSchink, A., Kadlec, K., Kaspar, H., Mankertz, J., & Schwarz, Š. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt123 · Cited by 59
Neonatal Meningitis Due to Escherichia coli K1
Glodé, M. P., Sutton, A., Robbins, J. B., McCracken, G. H., Gotschlich, E. C., KAIJSER, B., & Hanson, L. Å. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.supplement.s93 · Cited by 57
Johnson, J. R., Stell, A. L., O’Bryan, T. T., Kuskowski, M. A., Nowicki, B. J., Johnson, C. E., Maslow, J. N., Kaul, A., Kavle, J. A., & Prats, G. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.1913-1923.2002 · Cited by 56
Multidrug‐ResistantEscherichia coliClonal Groups Causing Community‐Acquired Pyelonephritis
Manges, A. R., Dietrich, P. S., & Riley, L. W. (2004) · Clinical Infectious Diseases · doi:10.1086/380640 · Cited by 55
Self-citationColomer-Lluch, M., Mora, A., López, C. M., Mamani, R. C., Dahbi, G., Marzoa, J., Herrera, A., Viso, S., Blanco, J., Blanco, M., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks477 · Cited by 54
Dahbi, G., Mora, A., López, C., Alonso, M. P., Mamani, R. C., Marzoa, J., Coira, A., Garcı́a-Garrote, F., Pita, J., Velasco, D., et al. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.017 · Cited by 52
Morris, D., Boyle, F., Ludden, C., Condon, I., Hale, J. L., O’Connell, N. H., Power, L., Boo, T. W., Dhanji, H., Lavallée, C., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05127-11 · Cited by 52
Kim, Y. A., Qureshi, Z. A., Adams‐Haduch, J. M., Park, Y. S., Shutt, K. A., & Doi, Y. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis387 · Cited by 52
When Carbapenem-Hydrolyzing β-Lactamase KPC Meets Escherichia coli ST131 in France
Naas, T., Cuzon, G., Gaillot, O., Courcol, R., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00719-11 · Cited by 51
Global Distribution and Epidemiologic Associations of Escherichia coli Clonal Group A, 1998–2007
Johnson, J., Menard, M. L., Lauderdale, T.-L. Y., Lauderdale, T.-L. Y., Kosmidis, C., Gordon, D., Collignon, P., Maslow, J. N., Andrašević, A. T., & Kuskowski, M. A. (2011) · Emerging infectious diseases · doi:10.3201/eid1711.110488 · Cited by 47
Dias, R. C. S., Marangoni, D. V., Smith, S. P., Alves, E. M., Pellegrino, F. L. P. C., Riley, L. W., & Moreira, B. M. (2009) · Microbial Drug Resistance · doi:10.1089/mdr.2009.0067 · Cited by 46
Self-citationThree-Decade Epidemiological Analysis of Escherichia coli O15:K52:H1
Olesen, B. R. S., Scheutz, F., Menard, M. L., Skov, M. N., Kolmos, H. J., Kuskowski, M. A., & Johnson, J. R. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00230-09 · Cited by 45
Ma, L., Siu, L.-K. K., Lin, J., Wu, T., Fung, C., Wang, J., Lu, P., & Chuang, Y.-C. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-599 · Cited by 45
Johnson, J. R., Anderson, J. T., Clabots, C., Johnston, B., & Cooperstock, M. S. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181c89bd7 · Cited by 44
Bacteraemia due to Escherichia coli in a Danish University Hospital, 1986-1990
Olesen, B. R. S., Kolmos, H. J., Ørskov, F., Ørskov, I., & Gottschau, A. (1995) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549509019018 · Cited by 35
Multidrug-resistant Escherichia coli clonal groups causing community-acquired bloodstream infections
Manges, A. R., Perdreau‐Remington, F., Solberg, O. D., & Riley, L. W. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.09.012 · Cited by 27
Self-citationThe rise and fall of Escherichia coli O 15 in a London Teaching Hospital
NEILL, P. M. O., Talboys, C. A., ROBERTS, A. P., & Azadian, B. S. (1990) · Journal of Medical Microbiology · doi:10.1099/00222615-33-1-23 · Cited by 25
Rapid and Specific Detection of the O15:K52:H1 Clonal Group of Escherichia coli by Gene-Specific PCR
Johnson, J. R., Owens, K., Sabate, M., & Prats, G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3841-3843.2004 · Cited by 23
Escherichia coli clonal group A causing bacteraemia of urinary tract origin
Skjøt-Rasmussen, L., Olsen, S. S., Jakobsen, L., Ejrnæs, K., Scheutz, F., Lundgren, B., Frimodt‐Møller, N., & Hammerum, A. M. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03961.x · Cited by 19
Escherichia coli bacteraemia. Serotype O15:K52:H1 as a urinary pathogen
Dalmau, D., Navarro, F., Mirelis, B., Blanco, J., Garau, J., & Prats, G. (1996) · Journal of Hospital Infection · doi:10.1016/s0195-6701(96)90073-0 · Cited by 19
Escherichia coli ST131: Variations on a theme of clonal expansion
Banerjee, R., & Johnson, J. R. (2013) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2013.01.004 · Cited by 14
MULTIRESISTANT INVASIVE ESCHERICHIA COLI INFECTION IN SOUTH LONDON
Wright, E. D., & Perinpanayagam, R. M. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90190-5 · Cited by 9
Platell, J. L., Cobbold, R. N., Johnson, J. R., Clabots, C., & Trott, D. J. (2012) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2012.02.002 · Cited by 8
Epidemic multi-resistant Escherichia coli infection in South London
Waghorn, D., KELLY, T. W. J., & Gibbins, W. (1988) · Journal of Hospital Infection · doi:10.1016/0195-6701(88)90063-1 · Cited by 7
Cited by
Sorted by citations
Mathers, A. J., Peirano, G., & Pitout, J. D. D. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-14 · Cited by 897
Sarowska, J., Futoma-Kołoch, B., Jama−Kmiecik, A., Frej−Mądrzak, M., Książczyk, M., Bugla‐Płoskońska, G., & Choroszy−Król, I. (2019) · Gut Pathogens · doi:10.1186/s13099-019-0290-0 · Cited by 786
The population genetics of pathogenic Escherichia coli
Denamur, É., Clermont, O., Bonacorsi, S., & Gordon, D. M. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0416-x · Cited by 731
Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages
Manges, A. R., Geum, H. M., Guo, A., Edens, T. J., Fibke, C. D., & Pitout, J. D. D. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00135-18 · Cited by 592
Antibiotic Resistance Among Uropathogenic Escherichia coli
Kot, B. (2019) · Polish Journal of Microbiology · doi:10.33073/pjm-2019-048 · Cited by 279
Metadata
- Authors
- Riley, L. W.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Riley, L.W.
- ORCID
- Riley, L.W.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 20
- Issue
- 5
- Pages
- 380-390
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W2027836512
- Cited by
- 412
- References
- 115
- Citations by year
- 2026: 18 · 2025: 43 · 2024: 42 · 2023: 46 · 2022: 47 · 2021: 37 · 2020: 57 · 2019: 36 · 2018: 22 · 2017: 24 · 2016: 17 · 2015: 19 · 2014: 4
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Clinical Microbiology and Infection (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Keywords
- extraintestinal pathogenic Escherichia coli, multilocus sequence typing, ST131, ST69, ST95, ST73, antimicrobial resistance, urinary tract infection, bloodstream infection, community-onset infection, nosocomial infections, clonal spread, bacterial fitness
- MeSH terms
- Escherichia coli, Escherichia coli Infections, Humans, Virulence, Bacterial Typing Techniques, Molecular Epidemiology, Cell Lineage, Drug Resistance, Bacterial, Pandemics, Multilocus Sequence Typing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review